相关实验视频

Updated: Jul 11, 2025

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

CD40/CD40L表达及其在宫癌的预后价值

G A Grazia^1,2, D R Bastos^1,2, L L Villa^1,2

¹Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

|November 16, 2023

概括

CD40和CD40L蛋白在状宫癌中表达高,具有作为预后标记物的潜力. 这一发现表明,这些免疫相关分子表达率较高的患者的生存率有所改善.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

CD40是一种瘤亡因子受体 (TNFR) 家族成员,调节免疫反应和抗瘤活性.
CD40在各种免疫和癌细胞上表达,包括宫癌,乳腺癌和黑色素瘤癌.

研究的目的:

调查宫癌中CD40和CD40L转录和蛋白质水平.
评估CD40/CD40L表达与宫癌亚型和患者存活率的关联.

主要方法:

在宫癌细胞系和瘤组织中分析CD40/CD40L表达.
使用公共数据集来检查不同宫瘤亚型中的CD40/CD40L表达.
将CD40/CD40L表达与整体生存数据相关联.

主要成果:

与腺癌相比,状细胞癌细胞系中的CD40表达率更高.
大约83%的状细胞癌在公共数据集中表达了CD40.
在状宫癌中增加CD40和CD40L表达与更好的整体存活率相关.

结论:

CD40和CD40L在状宫癌中显著表达.
这些蛋白质显示出作为宫癌预后生物标志物的潜力.
进一步探索CD40/CD40L作为宫癌的预后标志物是有必要的.

更多相关视频

Generation of Human CD40-activated B cells

Generation of Human CD40-activated B cells

Published on: October 16, 2009

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...